This new study shows a broad set of positive outcomes for Afrezza patients:
Healio: Inhaled insulin improves glucose control in type 1 diabetes.
The small study (26 subjects) randomly assigned patient to an inhaled vs injection regimen, thereby removing self-selection bias.
Positive outcomes:
The researchers observed more time in range, lower glucose standard deviation and less time in hyperglycemia in the inhaled insulin-compliant group
Postprandial glucose levels differed the most between the two groups 60 to 90 minutes after a meal, with postprandial glucose levels increasing in the insulin aspart group during the first hour after a meal, and dropping to their lowest point for the inhaled insulin group,